StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome total assets

Total assets on the balance sheet at the end of each period.

Cerenome's total assets was $14.03M at Jun 30, 2026. For fiscal 2025 it was $16.33M, up 146.1% from the year before. Over ten years it grew -8.0% a year on average. The highest annual figure on record is $66.35M in fiscal 2010.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.33M+146.1%
FY2024Dec 31, 2024$6.63M-41.8%
FY2023Dec 31, 2023$11.39M-52.3%
FY2022Dec 31, 2022$23.87M+8.6%
FY2021Dec 31, 2021$21.98M+81.6%
FY2020Dec 31, 2020$12.11M-47.9%
FY2019Dec 31, 2019$23.23M-3.2%
FY2018Dec 31, 2018$23.99M-24.1%
FY2017Dec 31, 2017$31.62M-8.7%
FY2016Dec 31, 2016$34.61M-8.2%
FY2015Dec 31, 2015$37.70M-2.6%
FY2014Dec 31, 2014$38.72M-7.9%
FY2013Dec 31, 2013$42.06M-2.8%
FY2012Dec 31, 2012$43.25M-16.1%
FY2011Dec 31, 2011$51.53M-22.3%
FY2010Dec 31, 2010$66.35M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.03M+35.6%
Q1 FY2026Mar 31, 2026$19.92M+65.2%
Q4 FY2025Dec 31, 2025$16.33M+146.1%
Q3 FY2025Sep 30, 2025$18.67M+167.6%
Q2 FY2025Jun 30, 2025$10.35M-7.7%
Q1 FY2025Mar 31, 2025$12.06M+114.5%
Q4 FY2024Dec 31, 2024$6.63M-41.8%
Q3 FY2024Sep 30, 2024$6.98M-47.4%
Q2 FY2024Jun 30, 2024$11.21M-21.0%
Q1 FY2024Mar 31, 2024$5.62M-64.1%
Q4 FY2023Dec 31, 2023$11.39M-52.3%
Q3 FY2023Sep 30, 2023$13.28M-42.5%
Q2 FY2023Jun 30, 2023$14.20M-33.3%
Q1 FY2023Mar 31, 2023$15.64M-36.2%
Q4 FY2022Dec 31, 2022$23.87M+8.6%
Q3 FY2022Sep 30, 2022$23.10M-6.7%
Q2 FY2022Jun 30, 2022$21.27M+2.1%
Q1 FY2022Mar 31, 2022$24.52M+33.7%
Q4 FY2021Dec 31, 2021$21.98M+81.6%
Q3 FY2021Sep 30, 2021$24.75M+112.4%
Q2 FY2021Jun 30, 2021$20.83M+49.8%
Q1 FY2021Mar 31, 2021$18.34M-12.5%
Q4 FY2020Dec 31, 2020$12.11M-47.9%
Q3 FY2020Sep 30, 2020$11.65M-54.7%
Q2 FY2020Jun 30, 2020$13.90M+56.5%
Q1 FY2020Mar 31, 2020$20.97M-14.8%
Q4 FY2019Dec 31, 2019$23.23M-3.2%
Q3 FY2019Sep 30, 2019$25.72M+0.7%
Q2 FY2019Jun 30, 2019$8.88M-66.7%
Q1 FY2019Mar 31, 2019$24.62M-22.1%
Q4 FY2018Dec 31, 2018$23.99M-9.3%
Q3 FY2018Sep 30, 2018$25.53M-21.4%
Q1 FY2018Mar 31, 2018$26.64M-10.5%
Q4 FY2017Dec 31, 2017$31.62M-8.7%
Q3 FY2017Sep 30, 2017$26.45M-28.2%
Q2 FY2017Jun 30, 2017$32.48M-23.9%
Q1 FY2017Mar 31, 2017$29.77M–
Q4 FY2016Dec 31, 2016$34.61M–
Q3 FY2016Sep 30, 2016$36.84M–
Q2 FY2016Jun 30, 2016$42.68M–

More Cerenome figures

See a number that looks wrong?